Inventor · disambiguated record
Morris Zimmerman
Also filed as: ZIMMERMAN MORRIS
11 granted patents·295 citations·filing 1975–1987
92Inventor score
Files withMERCK & CO INC11
Top patents by PatentIndex Score
11 records- 0196US4547371ASubstituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agentsMERCK & CO INC·Filed 1983·Granted Oct 15, 1985·56 cites·7 claims
- 0296US4276298A2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitorsMERCK & CO INC·Filed 1979·Granted Jun 30, 1981·53 cites·10 claims
- 0396US4195023A2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharinMERCK & CO INC·Filed 1975·Granted Mar 25, 1980·44 cites·3 claims
- 0494US4369183A2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitorsMERCK & CO INC·Filed 1981·Granted Jan 18, 1983·42 cites·9 claims
- 0590US4623645ASubstituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1983·Granted Nov 18, 1986·26 cites·10 claims
- 0685US4493839A1-Carbapenem-3-carboxylic esters as anti-inflammatory agentsMERCK & CO INC·Filed 1982·Granted Jan 15, 1985·17 cites·6 claims
- 0774US4495197AN-Carboxyl-thienamycin esters and analogs thereof as anti-inflammatory agentsMERCK & CO INC·Filed 1982·Granted Jan 22, 1985·9 cites·7 claims
- 0858US4465687AThienamycin derivatives as anti-inflammatory agentsMERCK & CO INC·Filed 1982·Granted Aug 14, 1984·18 cites·5 claims
- 0948US4891370ACephalosporin derivatives as anti-inflammatory agentsMERCK & CO INC·Filed 1981·Granted Jan 2, 1990·11 cites·9 claims
- 1048US4711886Aβ-lactam derivatives as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1984·Granted Dec 8, 1987·10 cites·6 claims
- 1143US4797396Aβ-Lactam derivatives as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1987·Granted Jan 10, 1989·9 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Morris Zimmerman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →